Citius Pharmaceuticals, Inc. — DEF 14A Filings
12 DEF 14A filings on record
This page lists all DEF 14A filings submitted to the SEC by Citius Pharmaceuticals, Inc. (CTXR), sorted by most recent first. Each row links to the full filing on EdgarLookup. Citius Pharmaceuticals, Inc. has filed 12 DEF 14A documents with the SEC since 2010. To view all SEC filings by Citius Pharmaceuticals, Inc., see the full filings list.
All
10-K
10-K/A
10-KT
10-Q
25-NSE
3
3/A
4
4/A
424B3
424B4
424B5
425
8-A12B
8-A12G
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
PRER14A
S-1
S-1/A
S-3
S-3/A
S-3MEF
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-26-019566 | Feb 24, 2026 | Apr 6, 2026 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-25-035755 | Apr 28, 2025 | Jun 9, 2025 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-25-006984 | Jan 27, 2025 | Mar 10, 2025 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-24-006971 | Jan 26, 2024 | Mar 12, 2024 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-22-082224 | Dec 22, 2022 | Feb 7, 2023 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-21-066329 | Dec 20, 2021 | Feb 8, 2022 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-21-021181 | Apr 12, 2021 | May 24, 2021 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-20-043792 | Dec 21, 2020 | Feb 9, 2021 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-19-026703 | Dec 20, 2019 | Feb 10, 2020 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-18-017613 | Dec 20, 2018 | Feb 13, 2019 |
| DEF 14A | DEFINITIVE PROXY STATEMENT | 0001213900-17-013195 | Dec 13, 2017 | Feb 7, 2018 |
| DEF 14A | DEF 14A | 0001477932-16-011779 | Aug 11, 2016 | Sep 15, 2016 |